Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.

Rachel Bronwen JonesShunsuke FurutaJan Willem Cohen TervaertThomas HauserRaashid LuqmaniMatthew D MorganChen Au PehCaroline O SavageMarten SegelmarkVladimir TesarPieter van PaassenMichael WalshKerstin WestmanDavid Rw Jaynenull null

Published in: Annals of the rheumatic diseases (2015)

ISRCTN28528813.

Keyphrases

diffuse large b cell lymphoma
high dose
low dose
study protocol
open label
hodgkin lymphoma
chronic lymphocytic leukemia
randomized controlled trial
clinical trial
double blind